Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Clinical trial NCT03742037 · COMPLETED
Trial details
- NCT number
- NCT03742037
- Sponsor
- Viatris Innovation GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2021-08-31
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.